Edition:
United States

Bovie Medical Corp (BVX)

BVX on American Stock Exchange

3.38USD
21 Feb 2017
Change (% chg)

$-0.12 (-3.43%)
Prev Close
$3.50
Open
$3.60
Day's High
$3.62
Day's Low
$3.33
Volume
78,347
Avg. Vol
123,191
52-wk High
$5.75
52-wk Low
$1.56

Summary

Name Age Since Current Position

Andrew Makrides

73 2013 Executive Chairman of the Board

John Saron

62 2011 President, Chief Sales and Marketing Officer, Director

Robert Gershon

48 2013 Chief Executive Officer, Director

Jay Ewers

2015 Chief Financial Officer

Moshe Citronowicz

62 2011 Senior Vice President

Jack McCarthy

49 2014 Chief Commercialization Officer

John Andres

57 2014 Independent Director

Michael Geraghty

68 2011 Independent Director

Lawrence Waldman

69 2011 Independent Director

Biographies

Name Description

Andrew Makrides

Mr. Andrew Makrides, Esq., is an Executive Chairman of the Board of Bovie Medical Corp. He received a Bachelor of Arts degree in Psychology from Hofstra University and a Juris Doctor Degree from Brooklyn Law School. He is a member of the Bar of the State of New York and practiced law from 1968 until joining Bovie Medical Corporation as a co-founder and Executive Vice President and director, in 1982. Mr. Makrides became President of the Company in 1985 and the CEO in December 1998 and has served as such until March 18, 2011 at which point he relinquished his position as President, but remained CEO until December 2013. Mr. Makrides employment contract extends to December 31, 2016. Mr. Makrides has over 29 years of executive experience in the medical industry.

John Saron

Mr. J. Robert Saron is President, Chief Sales and Marketing Officer, Director of Bovie Medical Corp. He holds a Bachelor degree in Social and Behavioral Science from the University of South Florida. From 1988 to present Mr. Saron has served as a director of the Company. Mr. Saron currently serves on an industry board as a director of the Health Industry Distributors Association Education Foundation. He previously served as both director and president of the Healthcare Manufacturers Management Council. Mr. Saron has received multiple industry awards. In 2008, Mr. Saron received the Health Industry Distributors Association’s highest award, the Industry Award of Distinction. In 2011, HMMC awarded Mr. Saron the Leonard Berke Achievement Award for ethics, mentoring, marketing skills, industry knowledge, and contributions to the industry and HMMC. Most recently, in February 2013, Mr. Saron was inducted into the Medical Distribution Hall of Fame. Mr. Saron brings over 35 years of executive marketing and distribution experience in the medical industry.

Robert Gershon

Mr. Robert L. Gershon is Chief Executive Officer, Director of Bovie Medical Corp. Mr. Gershon has over 25 years of healthcare industry experience. On the operations side he ran the largest sales and marketing business at Covidien (NYSE:COV). With over $1B in P&L responsibility, he consistently led an organization of over 600 people to double-digit revenue growth, outpacing market category growth and capturing significant market share points during challenging healthcare economic conditions. He also was VP of sales and marketing at Henry Schein ($1.4B shared P&L for medical division/$115M full P&L for dialysis division) and earlier in his career spent over 13 years as a healthcare consultant for Booz, Allen, KPMG and two boutique consultancies where his practice focused on strategic planning, business development and mergers and acquisitions. Mr. Gershon received an MBA from J.L. Kellogg Graduate School of Management at Northwestern University and a BSBA degree from American University. Mr. Gershon’s employment contract extends to December 31, 2015. Mr. Gershon’s employment contract extends to December 31, 2015.

Jay Ewers

Mr. Jay D. Ewers is Chief Financial Officer of the Company. He was Interim Chief Financial Officer, Treasurer, Secretary of the Company. He has more than 30 years of senior experience and has held financial executive positions in corporations ranging from early stage to high profile public companies with global operations in the medical equipment, manufacturing and semiconductor industries. He has extensive experience with Sarbanes Oxley, inventory management, Oracle modules and financial planning & analysis. Mr. Ewers is a certified public accountant, internal auditor, and holds a BS in Accounting. Jay Ewers is Interim Chief Financial Officer of the Company. cEwers has more than 30 years of senior experience and has held financial executive positions in corporations ranging from early stage to high profile public companies with global operations in the medical equipment, manufacturing and semiconductor industries. He has extensive experience with Sarbanes Oxley, inventory management, Oracle modules and financial planning & analysis. Mr. Ewers is a certified public accountant, internal auditor, and holds a BS in Accounting.

Moshe Citronowicz

Mr. Moshe Citronowicz is Senior Vice President of Bovie Medical Corporation. He is Senior Vice President came to the United States in 1978, and has worked in a variety of manufacturing and high technology industries. In October 1993, Mr. Citronowicz joined the Company as Vice President of Operations and served as our Chief Operating Officer until November 2011. Currently, he is serving as the Senior Vice President. Mr. Citronowicz’s employment contract extends to December 31, 2015.

Jack McCarthy

Mr. Jack McCarthy is Chief Commercialization Officer of Bovie Medical Corporation. Mr. McCarthy has 23 years of sales and marketing experience of which the last 16 years has been spent in the healthcare industry. Most recently, he served as Vice President of Sales and Marketing for US Healthcare at Z-Medica. Prior to that, Mr. McCarthy spent 15 years with Covidien (NYSE:COV), in positions of increasing responsibility where he was charged with achieving sales and business development goals. His most recent position at Covidien was as Area Sales Vice President for the Endo Mechanical Intelligent Device franchise, where he managed a team of 50 sales professionals. Mr. McCarthy is a graduate of Loyola College in Baltimore, Maryland, where he obtained a BA degree in Marketing in 1988 and an MBA in Marketing in 1990.

John Andres

Mr. John Andres has been appointed as an independent director of Bovie medical corporation. He has over thirty years of experience in the medical device industry. Since April, 2004, Mr. Andres has been a private consultant, doing business through John C. Andres, LLC, specializing in patent/business strategy development and execution. He also is a partner of Hawk Healthcare, LLC, which provides strategic transaction management to private individuals and companies. In 2004, Mr. Andres helped found K2M, Inc. (KTWO), and from 2004 until 2010 served as a member of the Board of Directors of K2M, Inc. Prior to 2004, Mr. Andres held various legal and strategic business development positions at the Surgical Division of Tyco Healthcare Group, LLP, now Covidien (NYSE: COV) and its predecessor, United States Surgical Corporation. Before joining U.S. Surgical, Mr. Andres worked at the New York law firm of Morgan & Finnegan. He received his Associate of Applied Science degree from Rochester Institute of Technology, his Bachelor of Arts degree from Lehigh University, and his Juris Doctor from Pace University School of Law.

Michael Geraghty

Mr. Michael E. Geraghty is Independent Director of Bovie Medical Corporation. He has served as a director since March 2011 and is the Executive Vice President of Global Sales at Optos, Inc., a developer and manufacturer of retinal imaging devices for screening, detection and diagnosis of eye related conditions. From 2005 through 2008, he was the President of International Sales at Gyrus Acmi where he first started in 2000 as Senior Vice President of Sales for Gyrus Medical. Prior to this, Mr. Geraghty was the Vice President of Sales and Marketing for Everest Medical, Inc. and before that was the Director of Marketing for Advanced Products at Arthrocare Corporation. Mr. Geraghty specializes in building independent direct sales teams in the medical device industry and has extensive domestic and international sales and marketing experience. He received his bachelor’s degree from St. Mary’s University and graduate degree in Executive Sales Management from the University of Minnesota.

Lawrence Waldman

Mr. Lawrence J. Waldman, CPA, is Independent Director of Bovie Medical Corporation. He has served as a director since March 2011 and is a certified public accountant. Mr. Waldman is currently the Partner-in-Charge of Commercial Audit Practice Development of the accounting firm EisnerAmper LLP. He has over forty years of experience in public accounting as an audit partner serving a wide range of clients. Prior to joining EisnerAmper LLP, Mr. Waldman was the Partner-in-Charge of Commercial Audit Practice Development for Holtz Rubenstein Reminick, LLP. Mr. Waldman was the Managing Partner of the Long Island office of KPMG LLP from 1994 through 2006, the accounting firm where he started at in 1972. Mr. Waldman is a former Chairman of the Board of Trustees of the Long Island Power Authority and served on the Finance and Audit Committee of the Board of Trustees. He is currently the Treasurer of the Long Island Association as well as a member of its Board of Directors and Chairman of the Finance Committee. In addition, Mr. Waldman is a member of the Board of Directors and Treasurer of each of the Long Island Angel Network and the Advanced Energy Research Center at Stony Brook University and a member of the Dean’s Advisory Board of the Hofstra University Frank G. Zarb School of Business. Mr. Waldman currently serves as a member of the Supervisory Committee of The Bethpage Federal Credit Union. Mr. Waldman received his bachelor’s degree and MBA from Hofstra University where he is also an adjunct professor. Mr. Waldman meets the definition of a financial expert as defined by the SEC and NYSE MKT.

Basic Compensation

Name Fiscal Year Total

Andrew Makrides

313,776

John Saron

414,183

Robert Gershon

545,220

Jay Ewers

--

Moshe Citronowicz

300,203

Jack McCarthy

650,929

John Andres

--

Michael Geraghty

--

Lawrence Waldman

--
As Of  30 Dec 2014